Keros Therapeutics, Inc.

For the period ended Jun 3, 2026. Filed Apr 22, 2026.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 3, 2026 · Filed Apr 22, 2026

KROS$9.36-1.0%Stored close · as of Nov 6, 2026

Opening this filing…